
Novamind (CSE: NM) Expands Psychedelic Medicine Access in Utah
Enhanced clinic enables greater access to ketamine and SpravatoTM treatments TORONTO, ON January 13, 2021 /Novamind Inc. (CSE:NM) (“Novamind” or the “Company”), a mental health company specialized in psychedelic medicine, announces the expansion and optimization of its Cedar […]